Volume 46, Issue 7 pp. 627-631
Original Article

Can we use portable nitric oxide analyzer in young children?

Satu Kalliola MD

Corresponding Author

Satu Kalliola MD

Department of Allergy, Helsinki University Central Hospital, Helsinki, Finland

Department of Allergy, Helsinki University Central Hospital, P.O. Box 160, Helsinki, FIN-00029 HUS, Finland.Search for more papers by this author
Pekka Malmberg MD PhD

Pekka Malmberg MD PhD

Department of Allergy, Helsinki University Central Hospital, Helsinki, Finland

Search for more papers by this author
Tuija Rito RN

Tuija Rito RN

Department of Allergy, Helsinki University Central Hospital, Helsinki, Finland

Search for more papers by this author
Anna S. Pelkonen MD PhD

Anna S. Pelkonen MD PhD

Department of Allergy, Helsinki University Central Hospital, Helsinki, Finland

Search for more papers by this author
Mika J. Mäkelä MD PhD

Mika J. Mäkelä MD PhD

Department of Allergy, Helsinki University Central Hospital, Helsinki, Finland

Search for more papers by this author
First published: 01 June 2011
Citations: 15

Conflict of interest: No financial or any other potential conflicts of interest exist.

Abstract

Objective

Management of asthma could be improved by measuring exhaled nitric oxide (FENO). Portable hand-held FENO analyzer (NIOX MINO) is practical and small and could be used also in the primary care office. It has demonstrated good repeatability and correlation with stationary device (NIOX) in adults and school aged children, but so far there have been no reports on young children. The aim of this study was to compare conventional chemiluminescence device (NIOX) with a hand-held electrochemical device (NIOX MINO) in young children.

Design

Paired measurements of FENO were performed with the stationary chemiluminescence-based analyzer (NIOX) and with portable electrochemical device (NIOX MINO) in children with asthmatic symptoms and age-matched controls.

Results

Fifty-five children with mean (range) age of 5.7 (3.9–8.5) years were evaluated with both devices. Measurements were successful with both devices in 40 out of 57 children. NIOX MINO was more difficult to use than NIOX in this age group, success rates being 73% and 93%, respectively (P = 0.004). The reproducibility was similar and there was a close correlation between FENO measured by the two devices (r = 0.97, P < 0.001). However, Bland–Altman plot demonstrated limits of agreement that were relatively wide compared to low levels of FENO in the sample. Both devices were sensitive enough to distinguish higher FENO levels in children with asthmatic symptoms, compared to healthy controls.

Conclusions

We conclude that NIOX MINO can be used as a screening tool for the assessment of airway inflammation in children from the age of 4 years, but its applicability is limited by lower measurement success rate and relatively poor accuracy and detection limit at low levels of FENO. Pediatr Pulmonol. 2011; 46:627–631. © 2011 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.